User menu

Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine : a potential marker of defective damage response

Bibliographic reference de Viron, Emeline ; Knoops, Laurent ; Connerotte, Thierry ; Smal, Caroline ; Michaux, Lucienne ; et. al. Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine : a potential marker of defective damage response. In: British Journal of Haematology, Vol. 147, no. 5, p. 641-652 (2009)
Permanent URL http://hdl.handle.net/2078.1/24560
  1. Austen, Journal of Clinical Oncology, 25, 5448 (2007)
  2. Baran-Marszak, Blood, 104, 2475 (2004)
  3. Bassett, Clinical Cancer Research, 14, 6376 (2008)
  4. Best, Leukemia, 22, 1456 (2008)
  5. Best, Leukemia, 23, 212 (2009)
  6. Bontemps, Biochemical Pharmacology, 59, 1237 (2000)
  7. Bowen, Leukemia and Lymphoma, 48, 2412 (2007)
  8. Burns, Molecular and Cellular Biology, 23, 5556 (2003)
  9. Byrd, Journal of Clinical Oncology, 19, 2153 (2001)
  10. Byrd, Journal of Clinical Oncology, 24, 437 (2006)
  11. Byrd, Blood, 109, 399 (2007)
  12. Carter, British Journal of Haematology, 127, 425 (2004)
  13. Carter, Leukemia, 20, 737 (2006)
  14. Castejon, Leukemia and Lymphoma, 50, 593 (2009)
  15. Catovsky, Lancet, 370, 230 (2007)
  16. Cheson, Blood, 87, 4990 (1996)
  17. Cobo, Leukemia, 16, 1028 (2002)
  18. Dohner, Blood, 85, 1580 (1995)
  19. Dohner, Blood, 89, 2516 (1997)
  20. Dreger, Leukemia, 21, 12 (2007)
  21. Faderl, Leukemia, 16, 1045 (2002)
  22. Fegan, Leukemia, 9, 2003 (1995)
  23. Ferrajoli, Blood, 111, 5291 (2008)
  24. Genini, Blood, 96, 3537 (2000)
  25. Grever, Journal of Clinical Oncology, 25, 799 (2007)
  26. Gryshchenko, Journal of Clinical Oncology, 26, 2252 (2008)
  27. Haferlach, Leukemia, 21, 2442 (2007)
  28. Johnson, Cancer Research, 69, 5210 (2009)
  29. Jones, Oncogene, 23, 1911 (2004)
  30. Kannan, Oncogene, 20, 2225 (2001)
  31. Keating, Journal of Clinical Oncology, 23, 4079 (2005)
  32. Kis, International Journal of Radiation Oncology ��� Biology ��� Physics, 66, 1506 (2006)
  33. Lee, Molecular and Cellular Biology, 27, 3187 (2007)
  34. Li, Proceedings of the National Academy of Sciences, 105, 15535 (2008)
  35. Lin, Blood, 100, 1404 (2002)
  36. Lopez-Guerra, Haematologica, 93, 1843 (2008)
  37. Lozanski, Blood, 103, 3278 (2004)
  38. Mackus, Leukemia, 19, 427 (2005)
  39. Mous, Leukemia, 23, 1352 (2009)
  40. Neilson, Leukemia, 11, 1929 (1997)
  41. Pettitt, Blood, 98, 814 (2001)
  42. Pettitt, Leukemia, 20, 1441 (2006)
  43. Pettitt, Haematologica, 92, 340 (2007)
  44. Riley, Nature Reviews Molecular Cell Biology, 9, 402 (2008)
  45. Rosenwald, Blood, 104, 1428 (2004)
  46. Sampath, Blood, 113, 3744 (2008)
  47. Shaffer, An international System for Human Cytogenetic Nomenclature (2005)
  48. Smith Paul, syed nelofer, Crook Tim, Epigenetic Inactivation Implies a Tumor Suppressor Function in Hematologic Malignancies for Polo-Like Kinase 2 but not Polo-Like Kinase 3, 10.4161/cc.5.12.2813
  49. Stankovic, Blood, 103, 291 (2004)
  50. Stilgenbauer, New England Journal of Medicine, 347, 452 (2002)
  51. Syed, Blood, 107, 250 (2006)
  52. Tam, Blood, 114, 957 (2009)
  53. Thornton P. D., Hamblin M., Treleaven J. G., Matutes E., Lakhani A. K., Catovsky D., High Dose Methyl Prednisolone in Refractory Chronic Lymphocytic Leukaemia, 10.3109/10428199909083393
  54. Trachootham, Blood, 112, 1912 (2008)
  55. Valganon, British Journal of Haematology, 129, 53 (2005)
  56. Van Den Neste, Leukemia, 16, 36 (2002)
  57. Van Den Neste, Biochemical Pharmacology, 65, 573 (2003)
  58. Van den Neste, International Journal of Oncology, 27, 1113 (2005)
  59. Van Den Neste, Leukemia, 21, 1715 (2007)
  60. Zenz, Blood, 112, 3322 (2008)
  61. Zenz, Blood, 113, 3801 (2009)